Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | LDHA | P00338 | 2/20 | 0.40 |
| ▸ | LDHB | P07195 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14870 | 1.00 | — | — | |
| SCHEMBL2128293 | 1.00 | TDP1 (1.00) | TDP1LMNABLMALOX15PMP22 | |
| Bromide SCHEMBL270286 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL160857 | 0.96 | — | — | |
| Water SCHEMBL11248400 | 0.96 | — | — | |
| Hydrogen Sulfide SCHEMBL8940298 | 0.96 | — | — | |
| Formaldehyde SCHEMBL1705724 | 0.96 | — | — | |
| SCHEMBL4561634 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL21838781 | 0.96 | TDP1 (0.92) | TDP1LMNABLMALOX15PMP22 | |
| Methyl Alcohol SCHEMBL8853832 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9622959-B2 | Cross-linked polymere | CLARIANT INTERNATIONAL LTD. (CH) | 2017-04-18 | — | — | US | disclosed |
| US-20140127147-A1 | Cross-linked Polymere | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-05-08 | — | — | US | disclosed |
| EP-0966488-B1 | PROCESS FOR INTRODUCING A FUNCTIONALITY | GE HEALTHCARE BIO SCIENCES AB (SE) | 2006-10-11 | — | — | EP | disclosed |
| US-6426315-B1 | Process for introducing a functionality | AMERSHAM PHARMACIA BIOTECH AB (SE) | 2002-07-30 | — | — | US | disclosed |
| EP-0966488-A1 | PROCESS FOR INTRODUCING A FUNCTIONALITY | Amersham Pharmacia Biotech AB (SE) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998039364-A1 | PROCESS FOR INTRODUCING A FUNCTIONALITY | AMERSHAM PHARMACIA BIOTECH AB (SE) | 1998-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140127147-A1 | Cross-linked Polymere | PCNA, SMC2, SMC1A | TDP1 929/4885LMNA 3609/4885BLM 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.